Skip to main content
Dennis Hallahan, MD, Radiation Oncology, Saint Louis, MO

DennisEHallahanMDFASTRO

Radiation Oncology Saint Louis, MO

Siteman Cancer Center/Washington University /BJH/National Academy of Inventors

Dr. Hallahan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hallahan's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    Dept Oncology
    Saint Louis, MO 63110
    Phone+1 314-747-7236
    Fax+1 314-362-8099

Education & Training

  • University of Chicago/University of Illinois College of Medicine at Chicago
    University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1986 - 1990
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1984 - 1986
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1984
  • University of Illinois
    University of IllinoisB.S., Biology, 1980

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1984 - 2026
  • MO State Medical License
    MO State Medical License 2009 - 2025
  • TN State Medical License
    TN State Medical License 1998 - 2011
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Elizabeth H. & James S. McDonnell III Distinguished Professor Washington University, 2009
  • The Alvin Siteman Cancer Research Award 2011
  • Fellow American Society for Radiology Oncology, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Radiation induced signal transduction through cPLA2 and Autotaxin.  
    Laszlo A, Thotala D, Hallahan DE, Lipid signaling, 1/1/2013
  • Membrane Phospholipids, EML4-ALK and Hsp90, as Novel Targets in Lung Cancer Treatment.  
    Laszlo A, Thotala D, Hallahan DE, The Cancer Journal, 1/1/2013
  • High-throughput identification of putative receptors for cancer-binding peptides using biopanning and microarray analysis.  
    Ferraro DJ, Bhave S, Kotipatruni R, Hunn J, Wildman S, Hong C, Jaboin J, Thotala D, Hallahan DE, Integrative Biology, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Mission and Vision of Washington Unviersity Dept of Radiation Oncology 
    Varian Medical Systems Retreat. - 1/1/2013
  • Highlights; Radiation guided delivery of nanoparticles. 
    NCI Workshop on image guided therapy. - 1/1/2013
  • Nanoparticles and drug delivery. 
    European Society for Radiation Oncology. - 1/1/2013
  • Join now to see all

Other

  •  
    Jacobs KM, Bhave SR, Ferraro DJ, Jaboin JJ, Hallahan DE, Thotala D
    1/1/2012
  • Microarray Informatic Array design name: VMSR M. musculus MEEBO 38.5K v1.0 
    Yazlovetzkaya E, Fu A, Hallahan DE
    http://www.ebi.ac.uk/arrayexpress/Submissions/
    European Bioinformatic Institute - 1/1/2005
  • Symposium Chair 
    Hallahan D
    Radiation Research. - 1/1/2000
  • Join now to see all

Press Mentions

  • Hugo Named Director of Medical Physics Division
    Hugo Named Director of Medical Physics DivisionAugust 3rd, 2021
  • Radiation Oncology Physics Coverage During the COVID‐19 Pandemic: Successes and Lessons Learned
    Radiation Oncology Physics Coverage During the COVID‐19 Pandemic: Successes and Lessons LearnedMarch 20th, 2021
  • Hallahan Named a National Academy of Inventors Senior Member
    Hallahan Named a National Academy of Inventors Senior MemberAugust 14th, 2019
  • Join now to see all

Grant Support

  • Lysophospholipids In Radiation Induced Signal Transduction In Malignant GliomasNational Cancer Institute2010–2012
  • X-RAY Targeted Therapeutic Genes Within NanoparticlesNational Cancer Institute2009–2011
  • Noninvasive Assessment Of Cancer Responsiveness To Therapy By Use Of .....National Cancer Institute2008–2011
  • Radioprotection By Use Of Topical Lithium FormulationsNational Cancer Institute2009
  • Pharmacodynamic Assessment Of RTK Inhibitors In CancerNational Cancer Institute2009
  • Nanoparticles Targeting Pancreatic CancerNational Cancer Institute2009
  • X-RAY Targeted Therapeutic Genes Within NanoparticlesNational Cancer Institute2007–2009
  • Pharmacodynamic Assessment Of RTK Inhibitors In CancerNational Cancer Institute2005–2009
  • Nanoparticles Targeting Pancreatic CancerNational Cancer Institute2007–2008
  • FLK1 Signaling Protects Tumor Vasculature From RadiationNational Cancer Institute2002–2008
  • X-RAY Guided Drug Delivery SystemsNational Cancer Institute2002–2004
  • Receptor Tyrosine Kinase Inhibition And RadiationNational Cancer Institute2001–2002
  • X-Rays Induce Exocytosis Of Endothelial P-SelectinNational Cancer Institute1999–2002
  • FLK1 Sinaling Protects Tumor Vasculature From RadiationNational Cancer Institute2001
  • X Ray Guided Drug Delivery Systems By ApcitideNational Cancer Institute2000–2001
  • Cell Adhesion Molecule Induction By Ionizing RadiationNational Cancer Institute1998–2001
  • Cell Adhesion Molecule Induction By Ionizing RadiationNational Cancer Institute1998
  • X-RAY Induction Of Tumor Necrosis Factor AlphaNational Cancer Institute1994–1997
  • X-RAY Induction Of Tumor Necrosis Factor-AlphaNational Cancer Institute1993